Sonoma Pharmaceuticals

📍 Boulder, United States👥 24 employees💰 Last funded 2021
Sonoma offers safe early-intervention solutions that provide fast relief and are free from side effects and other limitations. Sonoma Pharmaceuticals is a global healthcare leader dedicated to developing and commercializing innovative wound care and dermatological solutions. With over 20 years of experience, we have harnessed the power of our patented Microcyn® Technology to create a diverse product portfolio that addresses the needs of patients and healthcare professionals alike. Our mission is to improve patient outcomes by providing access to reliable, unique solutions that facilitate optimal conditions for wound care and skin health. We collaborate with the brightest minds in the industry and partner with our community to bring groundbreaking products to market, constantly pushing the boundaries of whats possible in healthcare.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals has 1 investors on record on gritt.io.
When did Sonoma Pharmaceuticals last raise funding?
The most recent investment in Sonoma Pharmaceuticals recorded on gritt.io was in 2021.
What industry is Sonoma Pharmaceuticals in?
Sonoma Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sonoma Pharmaceuticals based?
Sonoma Pharmaceuticals is headquartered in Boulder, United States.